Profile

Business Description

Nivalis Therapeutics is developing a novel class of disease modifying therapies that are designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule with cell signaling effects that are implicated in the pathophysiology of cystic fibrosis (CF).

Company Info

Address:
3122 Sterling Circle
Boulder, CO 80301 US

Telephone:
720-945-7700

Fax:
303-440-8399

Email:
info@nivalis.com

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
Research and Development in Biotechnology (541711)

SIC:
Pharmaceutical Preparations (2834)

Leaving Nivalis.com

Nivalis Therapeutics is not responsible for the content on linked websites.

The document you requested is located on the Journal of Applied Physiology website. A subscription is required to view the document.